Yttrium-90 Radioembolization Therapy for Combined Hepatocellular and Cholangiocarcinoma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Yttrium-90 Radioembolization Therapy for Combined Hepatocellular and Cholangiocarcinoma ; volume:7 ; number:4 ; year:2020 ; pages:144-150
Gastrointestinal tumors ; 7, Heft 4 (2020), 144-150
- Urheber
-
Badar, Wali
Van Ha, Thuong
Zangan, Steven
Navuluri, Rakesh
Pillai, Anjana
Baker, Talia
Ahmed, Osman
- DOI
-
10.1159/000508386
- URN
-
urn:nbn:de:101:1-2020101500203019326356
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:44 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Badar, Wali
- Van Ha, Thuong
- Zangan, Steven
- Navuluri, Rakesh
- Pillai, Anjana
- Baker, Talia
- Ahmed, Osman
Ähnliche Objekte (12)
Durvalumab-Induced Immune Thrombocytopenia in Patients with Advanced Cholangiocarcinoma Undergoing Yttrium-90 Radioembolization
Transarterial Radioembolization with Yttrium-90 for the Treatment of Hepatocellular Carcinoma
Planning Arteriography for Yttrium-90 Microsphere Radioembolization
Gastroduodenal ulceration following liver radioembolization with yttrium-90
Combined Hepatocellular-Cholangiocarcinoma: Biology, Diagnosis, and Management
Survival Benefit of Aggressive Treatment Approaches Incorporating Yttrium-90 Radioembolization for Late-Stage Hepatocellular Carcinoma
MRI features of combined hepatocellular- cholangiocarcinoma versus mass forming intrahepatic cholangiocarcinoma
Deep learning-based phenotyping reclassifies combined hepatocellular-cholangiocarcinoma
Clinicopathological characteristics and prognosis of combined hepatocellular cholangiocarcinoma
Standardizing SPECT/CT dosimetry following radioembolization with yttrium-90 microspheres
Clinicopathological features and recurrence patterns of combined hepatocellular-cholangiocarcinoma
A global evaluation of advanced dosimetry in transarterial radioembolization of hepatocellular carcinoma with Yttrium-90: the TARGET study
Durvalumab-Induced Immune Thrombocytopenia in Patients with Advanced Cholangiocarcinoma Undergoing Yttrium-90 Radioembolization
Transarterial Radioembolization with Yttrium-90 for the Treatment of Hepatocellular Carcinoma
Planning Arteriography for Yttrium-90 Microsphere Radioembolization
Gastroduodenal ulceration following liver radioembolization with yttrium-90
Combined Hepatocellular-Cholangiocarcinoma: Biology, Diagnosis, and Management
Survival Benefit of Aggressive Treatment Approaches Incorporating Yttrium-90 Radioembolization for Late-Stage Hepatocellular Carcinoma
MRI features of combined hepatocellular- cholangiocarcinoma versus mass forming intrahepatic cholangiocarcinoma
Deep learning-based phenotyping reclassifies combined hepatocellular-cholangiocarcinoma
Clinicopathological characteristics and prognosis of combined hepatocellular cholangiocarcinoma
Standardizing SPECT/CT dosimetry following radioembolization with yttrium-90 microspheres
Clinicopathological features and recurrence patterns of combined hepatocellular-cholangiocarcinoma
A global evaluation of advanced dosimetry in transarterial radioembolization of hepatocellular carcinoma with Yttrium-90: the TARGET study
Durvalumab-Induced Immune Thrombocytopenia in Patients with Advanced Cholangiocarcinoma Undergoing Yttrium-90 Radioembolization
Transarterial Radioembolization with Yttrium-90 for the Treatment of Hepatocellular Carcinoma
Planning Arteriography for Yttrium-90 Microsphere Radioembolization
Gastroduodenal ulceration following liver radioembolization with yttrium-90
Combined Hepatocellular-Cholangiocarcinoma: Biology, Diagnosis, and Management
Survival Benefit of Aggressive Treatment Approaches Incorporating Yttrium-90 Radioembolization for Late-Stage Hepatocellular Carcinoma
MRI features of combined hepatocellular- cholangiocarcinoma versus mass forming intrahepatic cholangiocarcinoma
Deep learning-based phenotyping reclassifies combined hepatocellular-cholangiocarcinoma
Clinicopathological characteristics and prognosis of combined hepatocellular cholangiocarcinoma
Standardizing SPECT/CT dosimetry following radioembolization with yttrium-90 microspheres
Clinicopathological features and recurrence patterns of combined hepatocellular-cholangiocarcinoma